Rydx S&P S-Cp 600 Pure Grw

Enova International amends merger agreement, removes shareholder option

Analyst Maintains Buy Rating on Enova International with Target Price of $189

Wyoming Reduces Holdings in InterDigital, Public Pension Increases

HSBC Holdings PLCCuts Holding in InterDigital Inc

Karin Eastham Sells 20,000 Veracyte Shares

Powell Industries' Operating VP Sells Company's Common Stock

InterDigital Inc. CTO Reports Sale of Company Common Stock

Prudential Financial Increased Holdings in Veracyte to $1 Million in Q2

Krish S Krishnan sold 50,000 shares of Krystal Biotech stock

Takeda and Protagonist Announce 52-Week Data for Rusfertide and Plan to Seek Regulatory Approval

Veracyte Inc. CEO reports common stock disposition

Corcept Therapeutics Inc Executives Sean Maduck Sold $1.6 Million in Stocks

Protagonist Therapeutics Sees Significant Revenue Growth with Janssen Collaboration

InterDigital Director Sells Common Stock

Veracyte Director Evan Jones Sells Company Common Stock

Enova International Amends Revolving Accounts Receivable Financing Agreement

William Blair Analyst Maintains Buy Rating on InterDigital

Veracyte Director Jens Holstein Disposes of Company Common Stock

Powell Industries Reports Record Profits, Sees Strong 2026 Outlook

Daikon Industries Q3 2026 Earnings Beat Expectations

Luminar Tech

Novabay Pharmac

Mint Incorporation

Autozi Internet Tech Global

GD Culture

Impact BioMedical

Tradr 2X Long FLY Daily ETF

Leverage Shares 2X Long CRWV Daily ETF

T-REX 2X Long CRWV Daily Target ETF

Ordinary dividend (cash)

Ex Date: 2025.12.22 (EST), Cash dividend 0.0493 USD

Dycom Industries Inc. announced that Board Member Luis Avila-Marco will retire at the 2026 Annual Meeting of Shareholders and will not seek reelection. The company plans to reduce its Board size from 10 to 9 members following his retirement.

Reuters

Dycom Industries

Dycom Industries Board Member Luis Avila-Marco to Retire at 2026 Annual Meeting

POWL

Mauney William Marshall Jr, VP of Powell Industries Inc, filed a Form 144 with the SEC to sell 3,000 shares of restricted stock on December 19, 2025. The sale will be conducted through Fidelity Brokerage Services. Filing Form 144 is a prerequisite for selling restricted securities, allowing the sale within 90 days of filing.

Powell Industries

VP Mauney Jr Files To Sell 3,000 Of Powell Industries Inc [POWL]

ENVA

David Fisher, CEO of Enova International, exercised stock options for 15,000 shares worth $2.08M, as disclosed in a recent SEC filing. Enova International provides online financial services and has shown a 16.34% revenue growth rate. However, the company faces challenges with a low gross margin, high debt-to-equity ratio, and below-average EPS. Despite a lower P/E and P/S ratio indicating potential undervaluation, its EV/EBITDA ratio is higher than industry benchmarks.

benzinga_article

Enova

Insider Decision: David Fisher Exercises Options At Enova International For $2.08M

Dec 18 (Reuters) - Enova International Inc ( ENVA ): * ‌ENOVA ​INTERNATIONAL - CO ‍AND GRASSHOPPER ⁠ENTERED ⁠INTO ‌AN AMENDMENT ​NO. 1 TO ⁠THE ‍MERGER ​AGREEMENT- SEC FILING * ENOVA ( ENVA ) ‍INTERNATIONAL -UNDER AMENDMENT, STOCKHOLDERS WILL NOT ​HAVE RIGHT ‍TO MAKE ELECTION & ​WILL INSTEAD RECEIVE BOTH CASH ​AND STOCK IN MERGER Source text: Further ‍company coverage: ;))

fidelity

BRIEF-Enova International - Co And Grasshopper Entered Into An Amendment No. 1 To The Merger Agreement- SEC Filing

Enova International Inc. has amended its merger agreement with Grasshopper Bancorp, maintaining core terms but filing changes with the SEC. Details are in Enova's latest SEC filing.

Enova Amends Merger Agreement With Grasshopper Bancorp

VCYT

Annie McGuire, Senior Vice President and General Counsel of Veracyte Inc., has reported the disposal of common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system.

Veracyte

Veracyte SVP and General Counsel Annie McGuire Reports Disposal of Common Shares

Powell Industries has seen strong growth with revenue up 26% and earnings up 86%. Despite a share price of $332.65, analysts suggest it may be overvalued with a fair value of $269.26. The consensus price target is $245.927, with differing analyst opinions. The article encourages exploring other investment opportunities and highlights key risks and rewards for Powell Industries.

Simplywall

Powell Industries (POWL): Is Strong Growth and Rising Free Cash Flow Already Fully Priced In?

AXTI

NAVN

AMKR

NKTR

GSAT

CRGY

SANM

CORT

AXT(AXTI) fell 12.34%, with a trading turnover 74.3 Million USD, and a year-to-date rose 499.1%. Navan(NAVN) fell 11.86%, with a trading turnover 92.1 Million USD, and a year-to-date fell 48.4%. PBF Energy(PBF) fell 10.99%, with a trading turnover 140.5 Million USD, and a year-to-date rose 4.9%.

Top Gainers & Losers

Navan

PBF Energy

Amkor Tech

Nektar Therap

Globalstar

Crescent Energy

Valaris

Sanmina

Corcept Therap

Top 10 US Stock Losers (12.16)

CCCS

GILD

UTHR

Fred Alger Management, LLC announced the quarterly rebalancing of the Alger Russell Innovation Index, effective after trading closes on December 19, 2025. Additions include CCC Intelligent Solutions, Amdocs, Duolingo, F5 Inc., GoDaddy, Gentex Corp., and Zebra Technologies. Deletions include Corcept Therapeutics, Electronic Arts, Gilead Sciences, Johnson & Johnson, Qorvo, United Therapeutics, and Vertex Pharmaceuticals.

prnewswire

CCC Intelligent Solutions

Gilead Sciences

United Therap

Electronic Arts

16:18 ET
			
			
				Alger Russell Innovation Index Updates for Fourth Quarter 2025

Analysts at H.C. Wainwright and Wolfe Research maintain positive views on Corcept Therapeutics, emphasizing confidence in Korlym and relacorilant's potential for Cushing’s syndrome. Despite ongoing legal and commercial challenges, relacorilant's long-term revenue potential and regulatory milestones are reshaping sentiment. The key catalyst is the December 30, 2025 PDUFA decision, with unresolved patent and antitrust disputes posing risks. Corcept's narrative projects $2 billion revenue by 2028, with a fair value estimate of $134.50 per share, indicating a 53% upside.

Does Corcept (CORT) Analysts’ Relacorilant Optimism Outweigh Ongoing Legal And Commercial Uncertainty?

Seaport Global analyst Bill Ryan maintained a Buy rating on Enova International (ENVA) with a price target of $189.00. BTIG also maintained a Buy rating with a $199.00 price target. Ryan is a 4-star analyst with a 13.1% average return and a 68.75% success rate.

Tip Ranks

Enova International (ENVA) Receives a Buy from Seaport Global

IDCC

State of Wyoming reduced its stake in InterDigital, Inc. by 63.4% in Q2, holding $775,000 worth of shares. Other investors adjusted their positions, with Public Sector Pension Investment Board increasing its stake by 6%. Analysts have varied ratings, with a consensus 'Buy' and an average price target of $416.67. InterDigital reported Q3 earnings of $1.93 per share, beating estimates, and announced a quarterly dividend of $0.70 per share.

Market Beat

InterDigital Comm

State of Wyoming Has $775,000 Position in InterDigital, Inc. $IDCC

Enova International (NYSE:ENVA) shares rose 10.2% to $155.87 with 161,046 shares traded. Analysts have mixed ratings, with some downgrading from strong-buy to buy or hold. The company reported strong Q3 earnings, authorized a $400 million share buyback, and insiders sold significant shares. Enova has a market cap of $3.93 billion, a PE ratio of 14.55, and a beta of 1.31. Institutional investors have adjusted their positions in the company.

Enova International (NYSE:ENVA) Trading Up 10.2%  - Time to Buy?

Jefferies analyst John Hecht maintained a Buy rating on Enova International (ENVA) with a price target of $165. Hecht, who covers the Financial sector, has an average return of 15.5% and a 60.68% success rate on recommended stocks. Enova International has a Strong Buy consensus among analysts, with a price target consensus of $173.80.

Enova International (ENVA) Gets a Buy from Jefferies

InterDigital, a research and development firm in Wilmington, Delaware, has seen its stock surge 87% this year due to its portfolio of 38,000 patents in cellular wireless technology, video streaming, and AI processing. The company ranks first on Forbes' 2025 list of America's Most Successful Mid-Cap Companies. Another top performer is Nextpower, a solar tracker company, which ranks fifth on the list with its stock up 140% in the past year.

Forbes

Nextpower

America’s Most Successful Mid Caps: Goldilocks Stocks Thriving In A Difficult Market